Targeting lipid metabolism in CAFs: A therapeutic opportunity in solid tumors

Key Points

• Modulating lipid metabolism in cancer-associated fibroblasts could significantly impact tumor growth and progression.
• Key metrics show altered lipid profiles associated with specific tumor types, indicating variability in therapeutic response.
• Assessment using clinical samples from various solid tumors highlights the role of the tumor microenvironment in therapy.
• This approach may enable novel strategies for targeting solid tumors; further research is needed to validate clinical outcomes.